Effect of IKERVIS® Eye Drops Once Daily on the Quality of Vision in Dry Eye Disease Patients With Severe Keratitis

Inclusion Criteria

• •Patient eligibility is determined according to the following criteria:
• •1. In the opinion of the investigator, the patient is capable of understanding and complying with protocol requirements.
• •2. The patient signs and dates a written, informed consent form and any required privacy authorization prior to the initiation of any study procedures
• •3. Male or female patient is aged 18 years or above.
• •4. DED patients with persistent severe keratitis at the Screening and
• •Baseline Visits defined as the following:
• •• CFS score of 3, 4 or 5 on the modified Oxford scale
• •5. Patient must be willing and able to undergo and return for scheduled study-related examinations.
• •6. The same eye (eligible eye) should fulfill all the above criteria.